Location History:
- Encinitas, CA (US) (2018)
- Grandview, NY (US) (2009 - 2019)
Company Filing History:
8 out of 67 
2 out of 1,309 
Years Active: 2009-2019
Title: The Innovations of Thomas A. Boyd
Introduction
Thomas A. Boyd is a notable inventor based in Grandview, NY (US), recognized for his contributions to pharmaceutical formulations. With a total of 8 patents to his name, Boyd has made significant advancements in the field of medicine, particularly in the development of stable pharmaceutical compositions.
Latest Patents
Among his latest patents, Boyd has developed stable pharmaceutical formulations of methylnaltrexone. These formulations are designed for effective administration and include methods for their production. Additionally, he has introduced new crystal forms of (R)-N-methylnaltrexone bromide, which serve as a peripheral mu opioid receptor antagonist. These innovations are crucial for enhancing the efficacy of treatments involving methylnaltrexone.
Career Highlights
Throughout his career, Thomas A. Boyd has worked with prominent companies in the pharmaceutical industry, including Progenics Pharmaceuticals, Inc. and Wyeth. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research and development in drug formulations.
Collaborations
Boyd has collaborated with esteemed colleagues such as Suketu Sanghvi and Howard Wagoner. These partnerships have fostered a collaborative environment that has led to significant advancements in their respective fields.
Conclusion
In summary, Thomas A. Boyd's innovative work in pharmaceutical formulations has made a lasting impact on the industry. His patents and collaborations reflect his dedication to improving medical treatments and advancing pharmaceutical science.